MedPath

雅安迅康药业有限公司

Ownership
-
Established
2015-04-15
Employees
-
Market Cap
-
Website
http://www.yaanxk.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

心可舒颗粒

Approval Number
国药准字Z20080611
Approval Date
Jan 9, 2023
NMPA

建曲

Approval Number
国药准字Z51020154
Approval Date
Nov 10, 2021
NMPA

半夏曲

Approval Number
国药准字Z51022380
Approval Date
Nov 10, 2021
NMPA

六神曲

Approval Number
国药准字Z51020155
Approval Date
Nov 10, 2021
NMPA

INDIGO NATURALIS

Product Name
青黛
Approval Number
国药准字Z51022575
Approval Date
Jun 29, 2021
NMPA

ARISAEMA CUM BILE

Product Name
胆南星
Approval Number
国药准字Z51022574
Approval Date
May 10, 2021
NMPA

PULVIS CORNUS BUBALI CONCENTRATUS

Product Name
水牛角浓缩粉
Approval Number
国药准字Z51022576
Approval Date
May 10, 2021
NMPA

地榆升白胶囊

Approval Number
国药准字Z20150018
Approval Date
Dec 17, 2019
NMPA

Sodium Phosphates Oral Solution

Product Name
磷酸钠盐口服溶液
Approval Number
国药准字H20103036
Approval Date
Jul 9, 2019
NMPA

Sodium Phosphates Oral Solution

Product Name
磷酸钠盐口服溶液
Approval Number
国药准字H20103035
Approval Date
Jul 9, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.